Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W M Halbmayer

Showing results (11-20 of 40) with videos related to

Pageof 4
Sort By:
Medizinische Klinik (Munich, Germany : 1983)|March 15, 1992
[Functional protein S in 77 patients treated with anticoagulants and in 32 probands with normal coagulation parameters]W M Halbmayer, C Feichtinger, K Rubi, et al.
Angiology|April 1, 1995
Quality assurance of high-dose i.v. heparin treatment exemplified by patients implanted with coronary Palmaz-Schatz stentsA Haushofer, W M Halbmayer, H Prachar, et al.
Lancet (London, England)|October 3, 1992
Inferior vena caval filters and systemic prothrombin activation in orally anticoagulated patientsW M Halbmayer, A Haushofer, E Toth, et al.
Thrombosis and Haemostasis|October 1, 1994
Influence of lupus anticoagulant on a commercially available kit for APC-resistanceW M Halbmayer, A Haushofer, R Schön, et al.
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|June 11, 1998
The 20210A allele of the prothrombin gene: a risk factor for juvenile stroke? Result of a pilot studyW M Halbmayer, A Haushofer, K M Hermann, et al.
Thrombosis and Haemostasis|September 7, 1992
The prevalence of factor XII deficiency in 103 orally anticoagulated outpatients suffering from recurrent venous and/or arterial thromboembolismW M Halbmayer, C Mannhalter, C Feichtinger, et al.
Hamostaseologie|January 6, 2006
[Recurrent miscarriage or failed in-vitro fertilization: antibodies against annexin V, cardiolipin, beta-2-glycoprotein-1 and APC-resistance]W M Halbmayer, W Feichtinger, C Kindermann, et al.
Journal of Clinical Pathology|May 1, 1996
Anti-GM1 antibodies in polyneuropathies of unknown originJ Finsterer, W Muellbacher, W M Halbmayer, et al.
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|August 24, 1999
Venous thromboembolism at a young age in a brother and sister with coinheritance of homozygous 20210A/A prothrombin mutation and heterozygous 1691G/A factor V Leiden mutationW M Halbmayer, T Kalhs, A Haushofer, et al.
Haemostasis|May 1, 1995
Comparison of a new automated kinetically determined fibrinogen assay with the 3 most used fibrinogen assays (functional, derived and nephelometric) in Austrian laboratories in several clinical populations and healthy controlsW M Halbmayer, A Haushofer, R Schön, et al.
Pageof 4

Showing results (11-20 of 40) with videos related to

Sort By:
Pageof 4
Medizinische Klinik (Munich, Germany : 1983)|March 15, 1992
[Functional protein S in 77 patients treated with anticoagulants and in 32 probands with normal coagulation parameters]W M Halbmayer, C Feichtinger, K Rubi, et al.
Angiology|April 1, 1995
Quality assurance of high-dose i.v. heparin treatment exemplified by patients implanted with coronary Palmaz-Schatz stentsA Haushofer, W M Halbmayer, H Prachar, et al.
Lancet (London, England)|October 3, 1992
Inferior vena caval filters and systemic prothrombin activation in orally anticoagulated patientsW M Halbmayer, A Haushofer, E Toth, et al.
Thrombosis and Haemostasis|October 1, 1994
Influence of lupus anticoagulant on a commercially available kit for APC-resistanceW M Halbmayer, A Haushofer, R Schön, et al.
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|June 11, 1998
The 20210A allele of the prothrombin gene: a risk factor for juvenile stroke? Result of a pilot studyW M Halbmayer, A Haushofer, K M Hermann, et al.
Thrombosis and Haemostasis|September 7, 1992
The prevalence of factor XII deficiency in 103 orally anticoagulated outpatients suffering from recurrent venous and/or arterial thromboembolismW M Halbmayer, C Mannhalter, C Feichtinger, et al.
Hamostaseologie|January 6, 2006
[Recurrent miscarriage or failed in-vitro fertilization: antibodies against annexin V, cardiolipin, beta-2-glycoprotein-1 and APC-resistance]W M Halbmayer, W Feichtinger, C Kindermann, et al.
Journal of Clinical Pathology|May 1, 1996
Anti-GM1 antibodies in polyneuropathies of unknown originJ Finsterer, W Muellbacher, W M Halbmayer, et al.
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|August 24, 1999
Venous thromboembolism at a young age in a brother and sister with coinheritance of homozygous 20210A/A prothrombin mutation and heterozygous 1691G/A factor V Leiden mutationW M Halbmayer, T Kalhs, A Haushofer, et al.
Haemostasis|May 1, 1995
Comparison of a new automated kinetically determined fibrinogen assay with the 3 most used fibrinogen assays (functional, derived and nephelometric) in Austrian laboratories in several clinical populations and healthy controlsW M Halbmayer, A Haushofer, R Schön, et al.
Pageof 4